Estrogen receptor ligands

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9586891
SERIAL NO

14234916

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estrogen receptor ligands.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KARO PHARMA AB111 48 STOCKHOLM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheng, Aiping Huddinge, SE 12 52
Garg, Neeraj Huddinge, SE 68 2096
Hagberg, Lars Huddinge, SE 7 7
Koch, Eva Huddinge, SE 18 41
Koehler, Konrad Huddinge, SE 9 31
Krüger, Lars Huddinge, SE 19 41
Löfstedt, Joakim Huddinge, SE 17 36
Nöteberg, Daniel Huddinge, SE 4 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00